Viracta Therapeutics Shares Are Trading Lower After Leerink Partners Downgraded the Stock From Outperform to Market Perform and Lowered Its Price Target From $5 to $3.
Viracta Therapeutics Shares Are Trading Lower After Leerink Partners Downgraded the Stock From Outperform to Market Perform and Lowered Its Price Target From $5 to $3.
Leerink Partners将Viracta Therapeutics的股票评级从跑赢大盘降为市场表现，并将其目标价从5美元降至3美元后，该股股价下跌。
Viracta Therapeutics Shares Are Trading Lower After Leerink Partners Downgraded the Stock From Outperform to Market Perform and Lowered Its Price Target From $5 to $3.
Leerink Partners将Viracta Therapeutics的股票评级从跑赢大盘降为市场表现，并将其目标价从5美元降至3美元后，该股股价下跌。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
资讯热榜
更新时间